TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED

Autres langues Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Actions

600329

CNE000001808

Produits pharmaceutiques

Cours en clôture Shanghai S.E. Autres places de cotation 19/05/2026			Varia. 5j.	Varia. 1 janv.
43,33 ^CNY	+1,95 %		+1,14 %	-5,02 %

30/04	La Bourse de Singapour bondit de plus de 1% portée par les revenus records de DBS	MT
30/04	Tianjin Pharmaceuticals Da Ren Tang : le résultat net bondit de 13% au T1, le titre grimpe de 5%	MT

Autres langues

30/04	Singapore Shares Surge More Than 1% as DBS Books Record Total Income
30/04	Tianjin Pharmaceuticals Da Ren Tang's Attributable Profit Jumps 13% in Q1; Shares Up 5%
29/04	Tianjin Pharmaceutical Da Ren Tang posts qtrly revenue of RMB1.52 billion
29/04	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2026
31/03	Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Drops 4.4% in 2025
31/03	Singapore Shares Remain in Red Amid Soaring Energy Costs; Rex International Plunges 20%
31/03	Tianjin Pharmaceutical Da Ren Tang to Renew Financial Services Agreement with Tianjin Pharmaceutical Group Finance
31/03	Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Down 4% in 2025
30/03	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Proposes Final Dividend for Fiscal Year 2025
30/03	Tianjin Pharmaceutical Da Ren Tang 2025 net profit down 4.4%
30/03	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2025
06/02	Controlling Shareholder Ups Stake in Tianjin Pharmaceutical Da Ren Tang; Shares Up 3%
02/02	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Interim Dividend for the Financial Year Ended 31 December 2025, Payable on or About February 12, 2026
15/12	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces the Cessation of Guo Xiumei as Employee Supervisor
15/12	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces the Cessation of Xie Xi as Supervisor
15/12	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces the Cessation of Wang Yuanxi as Chairman of the Supervisory Committee
26/11	Tianjin Pharmaceutical Da Ren Tang Gets China Approval for Pain Relief Patch
25/11	Tianjin Pharmaceutical Da Ren Tang's Unit Granted Registration Certificate by Chinese Authority
25/11	Tianjin Pharmaceutical Plant Receives Drug Registration Certificate
31/10/25	Tianjin Pharmaceutical Da Ren Tang Q3 Profit Up 54%, Revenue Down 38%
30/10/25	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Nine Months Ended September 30, 2025
30/10/25	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Proposes Interim Dividend for Fiscal Year 2025
30/10/25	Tianjin Pharmaceutical Da Ren Tang's Q3 Attributable Jumps 54% in Q3
14/08/25	Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Soars in Q2
14/08/25	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2025